AVAX One Technology Ltd. (NASDAQ: AVX) ("AVAX One” or the "Company”), today announced its financial and operating results for the first quarter ended March 31, 2026, along with an update on its AVAX ...
HV-106 study enrolment completed; doses selected for the global Phase 3 pivotal program of GH001 in TRDGH001-HV-109 US IND-opening study enrolment completedCash, cash equivalents and marketable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results